Short answer: marketing similarity is not the same as regulatory substantial equivalence.

Many founders believe that if their device “looks like” something already on the market, they can file a 510(k). That assumption is one of the most common regulatory mistakes in medical device development.

Under the framework of the U.S. Food and Drug Administration, a valid 510(k) depends on proving substantial equivalence—not surface-level similarity.

Those are very different standards.

What Substantial Equivalence Actually Means

To qualify for a 510(k), a device must demonstrate:

The same intended use as the predicate

The same or similar technological characteristics

That any differences do not raise new questions of safety or effectiveness

If technological differences exist, the manufacturer must provide data showing those differences do not increase risk.

This is a structured regulatory comparison—not a branding exercise.

What Founders Often Confuse With Equivalence
1. Similar Target Market

Just because two devices treat the same condition does not mean they share the same intended use.

For example:

A diagnostic device is not equivalent to a monitoring device

A screening tool is not equivalent to a treatment device

A general wellness claim is not equivalent to a clinical claim

Small wording differences in intended use can disqualify a predicate entirely.

2. Similar Appearance or Function

Devices that:

Look alike

Use similar terminology

Serve similar users

may still differ significantly in technological characteristics.

Differences in:

Materials

Software algorithms

Energy sources

Data interpretation

Mechanism of action

can create new safety questions—even if the user experience feels familiar.

FDA evaluates risk, not aesthetics.

3. Similar Marketing Positioning

Marketing claims are not regulatory equivalence arguments.

If your device claims:

Improved performance

Enhanced accuracy

Broader patient population

Expanded indications

you may have introduced new safety or effectiveness questions.

The more differentiation you market, the harder equivalence becomes.

Why This Matters

If substantial equivalence is weak:

FDA may issue additional information requests

The submission may receive a Refuse-to-Accept decision

The pathway may shift to De Novo

Development timelines may extend by 12–24 months

Capital requirements increase

Predicate mistakes rarely fail immediately. They fail under regulatory scrutiny.

What a Strong Predicate Analysis Looks Like

A defensible predicate strategy includes:

Detailed intended use comparison

Line-by-line technological comparison

Risk analysis tied to differences

Data plans addressing identified gaps

Clear justification that no new safety questions are introduced

Anything less is regulatory optimism.

Where Kandih Comes In

This is where Kandih Group performs structured predicate gap analyses.

Kandih supports teams by:

Conducting deep predicate landscape searches

Comparing intended use language precisely

Performing side-by-side technological mapping

Identifying differences that may trigger new safety questions

Assessing whether gaps can be closed with testing

Modeling fallback pathways if equivalence is weak

Instead of assuming a predicate works, founders understand where real regulatory gaps exist.

That prevents:

Weak 510(k) submissions

Unexpected pathway shifts

Investor confidence erosion

Costly rework

Bottom Line

Substantial equivalence is not about looking similar.
It is about demonstrating comparable risk.

Marketing similarity may win customers.
Regulatory equivalence is what wins clearance.

Understanding that difference early protects time, capital, and credibility.

References

FDA – Substantial Equivalence in Premarket Notifications (510(k))
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/substantial-equivalence-premarket-notifications-510k

FDA – Premarket Notification 510(k)
https://www.fda.gov/medical-devices/premarket-submissions/premarket-notification-510k

FDA – Refuse to Accept Policy for 510(k)s
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/refuse-accept-policy-510ks

FDA – Classify Your Medical Device
https://www.fda.gov/medical-devices/overview-device-regulation/classify-your-medical-device